Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTS-1027 + SOC in HCV Null-Responders
NCT01273064Phase 2Terminated
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- Jan 2011
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of CTS-1027 in hepatitis C virus infection, sponsored by Conatus Pharmaceuticals Inc.. Started Jan 2011; status: terminated.
02
Drugs
CTS-1027
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01273064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273064.